In this study the authors describe a novel strategy for stem cell-based bone regeneration. The authors demonstrate that Perivascular Stem Cells (PSCs), purified from human fat and combined with the protein NELL-1, can efficiently form bone nodules when implanted in a mouse muscle pocket. The novelty of this study resides in the injection of stem cells directly purified from fat without extensive manipulation in the laboratory, as conventionally done for Mesenchymal Stem Cell-based cell therapy, which could lead to loss of regenerative potential or cell transformation. Furthermore, the authors show that NELL-1 is a novel growth factor able to specifically stimulate bone and blood vessel formation without the side effect observed with the conventional bone-stimulating growth factor BMP2 (fat differentiation, inflammation, uncontrolled bone formation). This novel and safer stem cell application for bone regeneration based on the combination of non-cultured PSC and NELL-1 holds promise as a future cell-and-growth-factor-based therapeutic.
Funding Grants:
Harnessing native fat-residing stem cells for bone regeneration, UCLA CIRM Research Training
Program II
Public Summary:
In this study the authors describe a novel strategy for stem cell-based bone regeneration. The authors demonstrate that Perivascular Stem Cells (PSCs), purified from human fat and combined with the protein NELL-1, can efficiently form bone nodules when implanted in a mouse muscle pocket. The novelty of this study resides in the injection of stem cells directly purified from fat without extensive manipulation in the laboratory, as conventionally done for Mesenchymal Stem Cell-based cell therapy, which could lead to loss of regenerative potential or cell transformation. Furthermore, the authors show that NELL-1 is a novel growth factor able to specifically stimulate bone and blood vessel formation without the side effect observed with the conventional bone-stimulating growth factor BMP2 (fat differentiation, inflammation, uncontrolled bone formation). This novel and safer stem cell application for bone regeneration based on the combination of non-cultured PSC and NELL-1 holds promise as a future cell-and-growth-factor-based therapeutic.
Scientific Abstract:
An ideal mesenchymal stem cell (MSC) source for bone tissue engineering has yet to be identified. Such an MSC population would be easily harvested in abundance, with minimal morbidity and with high purity. Our laboratories have identified perivascular stem cells 
